Heart biopsy the first step
on a complex path

“Basically, when you’re talking about endomyocardial biopsy, it makes sense to broadly dichotomize the issue into the two categories that make sense clinically: transplant related and nontransplant related,” says Joseph Maleszewski, MD, section head of cardiovascular pathology, Mayo Clinic, Rochester, Minn.

Read the full story »

Dr. Joseph Maleszewski

Fresh options fuel lab asset reshuffle

“All the larger macroeconomic forces are driving change in health care—the transition from fee for service to fee for quality, bundled payments, the growth of networks, and the pressure on payers and providers to be as efficient as they can,” says Patrick Allen, managing director with the mergers and acquisitions practice of Kaufman, Hall and Associates in Skokie, Ill.

Read the full story »

Patrick Allen

With high-sensitivity troponins, watching and waiting continue

Laboratories and hospitals in the U.S. continue to look forward to high-sensitivity troponin assays. Judd E. Hollander, MD, says all he’s heard for the past five years is that an assay will be out at the end of the year. “And once you get halfway through the year, it will be out next year,” says Dr. Hollander, chair of the Department of Emergency Medicine and associate dean of strategic health initiatives at Sidney Kimmel Medical College of Thomas Jefferson University.

Read the full story »

Dr. Judd Hollander

Early days, early detection, early treatment for HIV

CAP TODAY asked Eileen Burd, PhD, D(ABMM), to discuss the evolution of HIV diagnostics and algorithms for using them and to give a qualitative evaluation of the pending fifth-generation assay. Dr. Burd is director of clinical microbiology, Emory University Hospital, and associate professor, Emory University School of Medicine, Atlanta.

Read the full story »

Dr. Eileen Burd

This Month’s Issue

Read, save, and print articles from the current issue

Articles

Chronological index
2013–2016

Product Guides

Compare all instruments
and software systems

Departments

Chronological index
2013–2015

Marketplace

New pathology lab products and industry news

Magazine Issue Archive

» 2013–2016 article index
»
2000–2012 article index

CAP TODAY Hosted Webinars

» Listen now: Standards for IHC Controls: Expert Recommendations
»
All on-demand webinars

Product Guides

» Compare products side-by-side
»
Download product guide PDFs

Quick Links

» Subscribe or renew CAP TODAY
»
Search for jobs / Post open positions

May 2016 Issue Articles

Click on the article title to read, save,
or print as a PDF

» Heart biopsy the first step on a complex path
» Fresh options fuel lab asset reshuffle
» With high-sensitivity troponins, watching and waiting continue
» All May 2016 articles

CAP TODAY Recommends

IHC testing’s impact on skin cancer

A free webinar sponsored by Sigma-Aldrich will review the utility of immunohistochemical testing with markers such as S-100, SOX-10, Ber-Ep4, and HHV-8 in accurately diagnosing skin cancer and improving survival rates for patients with the disease. Register.

Managing molecular information in the lab

As molecular technology and personalized medicine increasingly becomes the default position for clinical diagnostics laboratories, these modalities place significant demands on laboratory information systems. That is where molecular information management systems come into the picture. Download white paper.

The CPOE Lab Test: Utilization Opportunity

This editorial is brought to you through Roche’s Lab Leaders initiative.

The future of the lab in health care

CAP TODAY publisher Bob McGonnagle gathered with Orchard Software executives to discuss what lies ahead for laboratories.

» More CAP TODAY Recommends